BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38850785)

  • 1. Role of deubiquitinase USP47 in cardiac function alleviation and anti-inflammatory immunity after myocardial infarction by regulating NLRP3 inflammasome-mediated pyroptotic signal pathways.
    Wu Z; Li W; Wang S; Zheng Z
    Int Immunopharmacol; 2024 Jul; 136():112346. PubMed ID: 38850785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL4:NLRP3-mediated pyroptosis product that regulates cardiac fibrosis.
    Wei J; Peng MY; Wang SN; Lu HX
    Int Immunopharmacol; 2024 May; 133():112096. PubMed ID: 38657496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
    Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B
    J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.
    Palazón-Riquelme P; Worboys JD; Green J; Valera A; Martín-Sánchez F; Pellegrini C; Brough D; López-Castejón G
    EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30206189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ZNF883-Mediated NLRP3 Inflammasome Activation and Epilepsy Development Involve USP47 Upregulation.
    Gong L; Han Y; Chen R; Yang P; Zhang C
    Mol Neurobiol; 2022 Aug; 59(8):5207-5221. PubMed ID: 35678979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis.
    Wang X; Hu Y; Wang Y; Shen D; Tao G
    Biochem Cell Biol; 2021 Oct; 99(5):655-665. PubMed ID: 33939927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
    Shen S; He F; Cheng C; Xu B; Sheng J
    Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
    Shen J; Fan Z; Sun G; Qi G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
    Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP7-SOX9-miR-96-5p-NLRP3 Network Regulates Myocardial Injury and Cardiomyocyte Pyroptosis in Sepsis.
    Gong X; Li Y; He Y; Zhou F
    Hum Gene Ther; 2022 Oct; 33(19-20):1073-1090. PubMed ID: 35686454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese medicinal formula Fu Xin decoction against chronic heart failure by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway.
    Zhang L; Li Y; Fan CD; Jiang YH; Sheng LS; Song XY; Lin YX; Xue YT; Sun R
    Biomed Pharmacother; 2024 May; 174():116548. PubMed ID: 38599064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1β production, VWF release and NET deposition in the myocardium.
    Heger LA; Schommer N; Van Bruggen S; Sheehy CE; Chan W; Wagner DD
    Sci Rep; 2024 Jun; 14(1):14524. PubMed ID: 38914598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM16 exerts protective function on myocardial ischemia/reperfusion injury through reducing pyroptosis and inflammation via NLRP3 signaling.
    Shi M; Su F; Dong Z; Shi Y; Tian X; Cui Z; Li J
    Biochem Biophys Res Commun; 2022 Dec; 632():122-128. PubMed ID: 36208489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.
    Bian Y; Li X; Pang P; Hu XL; Yu ST; Liu YN; Li X; Wang N; Wang JH; Xiao W; Du WJ; Yang BF
    Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
    Sharma BR; Karki R; Rajesh Y; Kanneganti TD
    J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil extracellular traps induce pyroptosis of pulmonary microvascular endothelial cells by activating the NLRP3 inflammasome.
    Zhao P; Zhu J; Bai L; Ma W; Li F; Zhang C; Zhao L; Wang L; Zhang S
    Clin Exp Immunol; 2024 Jun; 217(1):89-98. PubMed ID: 38517050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.
    Chen F; Chen ZQ; Zhong GL; Zhu JJ
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1938-1947. PubMed ID: 34034564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    Takahashi M
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia.
    Ye X; Lin ZJ; Hong GH; Wang ZM; Dou RT; Lin JY; Xie JH; Shen YW
    Exp Cell Res; 2024 May; 438(2):114061. PubMed ID: 38692345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.